AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KAUG 76 min read$CTEV

Claritev Corp (CTEV): Results of Operations and Financial Condition

Claritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202

Original reporting
SEC EDGAR 8-K
Published Aug 7, 2026, 10:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 10:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CTEV
Bullish
medium confidence
Mentioned
$CTEV
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CTEVBullishMed
01

Why it matters

Traders can update models around the updated revenue, Adjusted EBITDA, and free cash flow ranges, and reassess near-term expectations ahead of the scheduled earnings call.

02

Market read

Q2 results show YoY revenue growth and improved operating cash flow and free cash flow, alongside updated FY 2026 guidance ranges.

03

What to watch

Unrestricted cash is only $14.4M at quarter end, and free cash flow guidance remains relatively tight ($5M-$15M), so liquidity and conversion risk may matter more than headline revenue growth.

Relevance 7/10Novelty 8/10Timing: pre-market today, Aug 7, 2026 8:00 a.m. ET conference call

Background

This is an SEC Form 8-K (Item 2.02) with an attached earnings press release covering Q2 2026 results and updated FY 2026 guidance.

Company-level read

Ticker impact

$CTEVBullishMedium confidence
Context

Claritev reported Q2 2026 results and updated full-year 2026 guidance, including revenue $1.00B-$1.02B and Adjusted EBITDA $610M-$620M.

Expected impact

Moderate upside bias if investors view the updated revenue and EBITDA range as credible and FCF trajectory improving.

Evidence & confidence

Q2 shows year-over-year revenue growth and higher operating cash flow and free cash flow, and management raised/updated full-year ranges; however, the release does not include consensus comparisons or a clear surprise magnitude.

Market effects

Sector

Healthcare data and insights peers may see read-through on demand strength and AI-driven execution narratives, but impact is likely company-specific.

Regional

Limited, as the disclosure is issuer-specific with no broader regional macro signal.

Global

Low, since the guidance and results are not tied to global regulatory or cross-border events.

Counterpoint

What could challenge this read

Despite revenue growth, the company still reported a large net loss, and Adjusted EBITDA margin declined versus Q2 2025, which could temper enthusiasm.

Key entities

  • issuer
    Claritev Corporation

    Technology, data, and insights company focused on healthcare affordability, transparency, and fairness.

  • executive
    Travis Dalton

    Chairman, CEO, and President, quoted on strategy execution and bookings strength.

  • executive
    Doug Garis

    CFO, quoted on revenue and Adjusted EBITDA performance and client success focus.

Read at source← All news

Related articles

AUG 9
$CTEVMedAI 8/10

Claritev Q2 Earnings Call Highlights

Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.

yahoo.com5 min
SEP 22
Med

DroneShield Shares Down 50% This Year, As Pressure Builds

DroneShield (ASX: DRO) shares have fallen 50% in 2026, despite a 74% revenue increase to A$125.8M. The company reported a net loss of A$32.2M, causing concern about profitability. Brokers have mixed price targets, ranging from A$1.50 to A$2.60. The stock trades at A$1.66, below the A$1.70 support level.

thebull.com.au3 min
SEP 22
$KBHMedAI 8/10

KB Home’s (NYSE:KBH) Q3 CY2026 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations

KB Home (NYSE: KBH) reported Q3 CY2026 revenue of $1.30B, meeting expectations but down 20% YoY. Full-year guidance of $5B missed estimates by 2%. EPS of $1.05 beat estimates by 16.7%. The company highlighted progress in its Built to Order business and community count growth. Analysts expect 6.5% revenue growth and 19.7% EPS growth over the next 12 months.

financialcontent.com2 min
SEP 22
$KBHHigh

Why is KB Home stock sliding today?

KB Home stock fell 2.7% in after-hours trading after reporting fiscal Q3 earnings. EPS beat estimates at $1.05, but revenue of $1.3B dropped 20% YoY. Full-year revenue guidance was 2% below expectations. Operating and gross profit margins declined, and net orders fell 12% YoY. The company cited weakening conditions and higher mortgage rates. Ending backlog rose, and $50M in stock was repurchased. The stock had already declined over 20% in the past year.

investing.com2 min